Millennium Management’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-441,684
Closed -$43.5M 5994
2025
Q2
$43.5M Sell
441,684
-163,893
-27% -$15.5M 0.02% 906
2025
Q1
$56.1M Buy
605,577
+220,003
+57% +$20.3M 0.03% 688
2024
Q4
$35M Sell
385,574
-159,210
-29% -$14.6M 0.02% 1046
2024
Q3
$52.6M Sell
544,784
-313,933
-37% -$30.6M 0.02% 784
2024
Q2
$78.8M Sell
858,717
-348,036
-29% -$32.3M 0.04% 526
2024
Q1
$111M Buy
1,206,753
+19,577
+2% +$1.83M 0.05% 404
2023
Q4
$113M Buy
1,187,176
+380,411
+47% +$35.5M 0.05% 369
2023
Q3
$75.4M Buy
806,765
+605,423
+301% +$55.9M 0.04% 495
2023
Q2
$18.4M Sell
201,342
-188,784
-48% -$15.5M 0.01% 1464
2023
Q1
$28.7M Sell
390,126
-87,955
-18% -$7.61M 0.02% 1070
2022
Q4
$39.9M Buy
478,081
+359,891
+305% +$32.4M 0.02% 899
2022
Q3
$11.4M Buy
118,190
+104,289
+750% +$12.4M 0.01% 1967
2022
Q2
$1.46M Sell
13,901
-208,633
-94% -$26.7M ﹤0.01% 4014
2022
Q1
$38.3M Buy
222,534
+214,360
+2,622% +$32M 0.02% 861
2021
Q4
$1.32M Sell
8,174
-83,680
-91% -$13.4M ﹤0.01% 4143
2021
Q3
$13.7M Buy
91,854
+17,315
+23% +$3.6M 0.01% 1685
2021
Q2
$18.3M Buy
74,539
+11,251
+18% +$2.95M 0.01% 1282
2021
Q1
$16.8M Sell
63,288
-34,357
-35% -$9.69M 0.01% 1244
2020
Q4
$28.6M Sell
97,645
-27,416
-22% -$7.03M 0.02% 803
2020
Q3
$29.6K Sell
125,061
-82,680
-40% -$18.8M 0.04% 564
2020
Q2
$41.2M Buy
207,741
+176,359
+562% +$32.9M 0.06% 362
2020
Q1
$5.76M Sell
31,382
-18,238
-37% -$3.24M 0.01% 1228
2019
Q4
$8.28M Buy
49,620
+23,521
+90% +$3.5M 0.01% 1535
2019
Q3
$3.42M Buy
26,099
+14,512
+125% +$1.89M 0.01% 2080
2019
Q2
$1.41M Sell
11,587
-225,180
-95% -$26.7M ﹤0.01% 2610
2019
Q1
$29.2M Buy
236,767
+14,254
+6% +$1.79M 0.04% 579
2018
Q4
$26.1M Buy
222,513
+88,634
+66% +$10.4M 0.04% 586
2018
Q3
$16.7M Sell
133,879
-34,296
-20% -$3.79M 0.02% 937
2018
Q2
$14.4M Sell
168,175
-82,298
-33% -$6.04M 0.02% 1078
2018
Q1
$15.1M Sell
250,473
-797,950
-76% -$45.5M 0.02% 1060
2017
Q4
$55.3M Buy
1,048,423
+435,734
+71% +$23M 0.08% 372
2017
Q3
$34.3M Buy
612,689
+457,729
+295% +$24.2M 0.05% 500
2017
Q2
$9.73M Buy
154,960
+12,950
+9% +$754K 0.02% 1070
2017
Q1
$7.25M Buy
142,010
+108,857
+328% +$5.19M 0.01% 1225
2016
Q4
$1.41M Buy
+33,153
New +$1.41M ﹤0.01% 2064
2016
Q3
Sell
-90,661
Closed -$4.58M 3244
2016
Q2
$4.58M Buy
90,661
+45,640
+101% +$2.3M 0.01% 1321
2016
Q1
$2.18M Sell
45,021
-69,233
-61% -$2.67M 0.01% 1723
2015
Q4
$4.49M Sell
114,254
-169,103
-60% -$6.76M 0.01% 1437
2015
Q3
$10.8M Sell
283,357
-262,725
-48% -$11.1M 0.02% 894
2015
Q2
$21.7M Sell
546,082
-229,762
-30% -$7.16M 0.04% 585
2015
Q1
$20.8M Buy
775,844
+461,241
+147% +$13M 0.04% 645
2014
Q4
$9.23M Sell
314,603
-108,501
-26% -$2.68M 0.02% 1041
2014
Q3
$8.53M Buy
423,104
+408,504
+2,798% +$7.88M 0.02% 955
2014
Q2
$244K Sell
14,600
-9,908
-40% -$140K ﹤0.01% 2995
2014
Q1
$365K Sell
24,508
-23,499
-49% -$362K ﹤0.01% 2822
2013
Q4
$702K Buy
48,007
+17,479
+57% +$281K ﹤0.01% 2508
2013
Q3
$525K Buy
+30,528
New +$453K ﹤0.01% 2507

Other funds holding AMED

Millennium Management's AMED Position: Q3 2025 in Review

Millennium Management sold out of Amedisys (AMED) in Q3 2025, closing a stake of 441,684 shares — an estimated $43.5M sold.

Millennium Management first reported a position in AMED in Q3 2013 and held it in 47 quarters. The position peaked at $113M in Q4 2023. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Millennium Management reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Millennium Management sold 441,684 Amedisys shares in Q3 2025, an estimated $43.5M.
  • Millennium Management first reported a position in Amedisys in Q3 2013 and held it in 47 quarters.
  • Millennium Management's Amedisys position peaked at $113M in Q4 2023.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Millennium Management's 13F filing for Q3 2025, filed 14 Nov 2025.